Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04838418

Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest

Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest (TOMCAT)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University Hospital Pilsen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In sudden cardiac arrest patients with return of spontaneous circulation, brain damage is one of the main determinants of short-term mortality and poor prognosis (CPC 3-5). It is important to properly select group of patients in whom treatment is futile. According to current guidelines, multimodal approach is recommended. Optic nerve sheath diameter measured by ultrasound is non-invasive, fast, low-cost and readily available bed-side method, but evidence for its use as neuroprognostication modality is limited to only few small studies. The aim of this study is to evaluate validity of ONSD as neuroprognostication method at larger cohort of patients, compare it with other established methods and compare ultrasound and CT measurement of ONSD.

Detailed description

Additional relevant MeSH terms: cardiac arrest, cardiovascular diseases, optic nerve sheath diameter.

Conditions

Interventions

TypeNameDescription
PROCEDUREOptic nerve sheath diameter measured by transorbital ultrasoundOptic nerve sheath diameter measured 3 mm behind eyeball. For every eyeball 2 measurements in axial and 2 measurements in sagital projections are performed. Summary value for every eyeball is arithmetic mean from these 4 measurements.

Timeline

Start date
2021-01-04
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2021-04-09
Last updated
2026-04-09

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT04838418. Inclusion in this directory is not an endorsement.